Erle T. Mast, Director at Sienna Biopharmaceuticals, Inc. (SNNA), bought 6,700 shares at $15.00 ($101K) on 2017-08-01, disclosed to the SEC on 2017-08-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-10-02 | $271K | — | Filing → |
| CLVS | SELL | 2015-09-03 | $239K | — | Filing → |